Home R&D Drug Delivery Page 2

Drug Delivery

Migalastat for the treatment of Fabry disease

ADA-SCID: an Italian success

First oral treatment for Fabry disease recommended for approval in the EU

Conditional approval for blinatumomab to treat B-precursor ALL

Mepolizumab in the treatment of asthma

First digital medicine application accepted by FDA

Guanfacine to treat attention deficit hyperactivity disorder

Alirocumab to treat adults with primary hypercholesterolaemia

Lamivudine and raltegravir together to treat HIV

Pegfilgrastim against tumor side effects

1234Page 2 of 4
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151